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A toxin from an enteropathogenic strain of Escherichia coli (E. coli H30) was
purified to apparent homogeneity from cell lysates. The steps used to isolate the
E. coli H30 toxin included French pressure-cell disruption of bacteria grown in
iron-depleted media, Affi-Gel Blue chromatography, chromatofocusing, and antiShiga toxin affinity chromatography. The mobilities of the subunits of radioiodinated E. coli H30 toxin and Shiga toxin observed after the two toxins were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis were
identical. In the absence of 2-mercaptoethanol, a narrow band was seen at Mr
31,500 (±1,000), and a wide heavy band was observed between Mr 4,000 and
15,000. In the presence of 2-mercaptoethanol, bands were seen at Mr 31,500
(±1,000), 27,000, and 4,000 to 15,000. Other similarities between purified E. coli
H30 and Shiga 60R toxins included identical isoelectric points (7.03 ± 0.02);
comparable biological activities, i.e., cytotoxicity, lethality for mice, and enterotoxicity; and the same relative heat stabilities (up to 65°C for 30 min). Nevertheless, the two toxins had apparently different molecular weights as determined by
sucrose gradient analysis, by gel filtration, and by cross-linking experiments with
dimethyl suberimidate. The Mr of native E. coli H30 toxin estimated from crosslinking studies was 48,000, whereas the estimated Mr of Shiga 60R toxin was
58,000. These results suggest that like the cholera-E. coli-heat-labile toxin family,
a family of Shiga-like toxins exists.

Escherichia coli is one of several agents responsible for acute bacterial gastroenteritis.
Two pathogenic mechanisms have been described by which E. coli can mediate diarrhea
(8). Some strains of E. coli colonize the mucosal
surface of the small bowel and elaborate heatlabile or heat-stable enterotoxins or both that
cause fluid secretion and, hence, diarrhea (30).
In contrast to these noninvasive enterotoxigenic
strains, other E. coli isolates are serologically
related to the shigellae (10) and, like shigellae,
they are able to penetrate and multiply within
colonic epithelial cells (8). These enteroinvasive
E. coli strains are recognized by their ability to
evoke keratoconjunctivitis in guinea pigs (Sereny test, reference 27). Strains of a third group
designated by serotype as enteropathogenic E.
coli (EPEC) have been incriminated as agents of
epidemic and endemic diarrheal disease in infants (1, 26), but they are not enteroinvasive, nor
do they produce heat-labile or -stable enterotoxins (12). Recent studies from this laboratory (20)
revealed that most EPEC and some other E. coli

enteric isolates (heat-labile and -stable enterotoxin-positive organisms and an enteroinvasive
strain) make a cell-associated cytotoxin that can
be neutralized by antitoxin prepared against the
purified toxin of Shigella dysenteriae 1 (Shiga).
Moreover, like Shiga extracts, cell lysates of
certain EPEC strains are also enterotoxic for
rabbit ileal segments and lethal and paralytic for
mice. That a cell-associated cytotoxin could be a
virulence determinant in EPEC strains is suggested by the observation that the destruction of
gut epithelial cell microvilli seen on small bowel
biopsies of human infants with EPEC diarrhea is
confined to regions of dense E. coli adherence
(5, 25). In this investigation, the Shiga-like toxin
from one EPEC strain, E. coli H30, was purified
to apparent homogeneity, and its biological and
biochemical characteristics were compared with
those of Shiga toxin.
MATERIALS AND METHODS
Bacterial strains. E. coli H30, an 026 EPEC isolate
(14), was used as the source of Shiga-like toxin (20).
Shiga toxin was prepared from Shigella dysenteriae 1
strain 60R (7).
Antitoxin. Monospecific antitoxin against purified

t Present address: Laboratory of Human Carcinogenesis,
National Institutes of Health, Bethesda, MD 20814.
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Shiga 60R toxin was raised in rabbits by injection of
toxin-antitoxin complexes, as previously described

(19).

Preparation of bacterial extracts. Iron-depleted syncase broth was prepared by a previously described
method (18, 20). Organisms were incubated for 48 h
with shaking (280 rpm) at 37°C. Culture volumes were
typically 8 to 12 liters. Bacteria were harvested by
centrifugation, washed, and disrupted in a French
pressure cell, and extracts were clarified by ultracentrifugation as detailed elsewhere (19).
Toxin purification. French press extracts were dialyzed against 100 volumes of 10 mM sodium phosphate
buffer (pH 7.4) and then were applied to a column (2.5
by 23 cm) that contained 50 ml of Affi-Gel Blue (BioRad Laboratories, Richmond, Calif.), a chromatographic procedure originally used by Olsnes et al. (23).
The column was then washed with 10 mM sodium
phosphate buffer (pH 7.4) until the optical density at
280 nm (OD280) was <0.050. Material which had
bound to the column was eluted with 500 mM NaCl in
10 mM sodium phosphate (pH 7.4). A pool of this
eluate was then dialyzed against 200 volumes of 25
mM Tris (pH 8.3). Next, the partially purified toxin
was concentrated to a volume of 5 ml on an Amicon
concentrator with a YM-10 membrane (Amicon Corp.,
Lexington, Mass.). The concentrated toxin was then
applied to a column (0.9 by 30 cm) that contained 20 ml
of polybuffer exchanger PBE 94 (Pharmacia, Uppsala,
Sweden) which had been equilibrated with 25 mM Tris
(pH 8.3). This ion-exchange column was eluted with a
mixture of polybuffer 96 and polybuffer 74 as described by Pharmacia ("Chromatofocusing with Polybuffer and PBE," technical brochure) to generate a pH
gradient between pH 8.0 and 5.0. Increments of 0.02
pH units were formed per 2-ml column fraction. By
this chromatofocusing procedure, the HeLa cell cytotoxic peak fraction occurred between pH 6.9 and 7.1.
The peak sample and the two fractions on either side
of it were pooled and applied to a 40-ml column of
rabbit anti-Shiga toxin linked to Sepharose 4B (Pharmacia) that had been prepared as previously described
(19). The antitoxin column was washed with 140 mM
NaCl in 10 mM phosphate (pH 7.4) until the OD280 was
c0.005. Bound toxin was eluted with 3.5 M MgCi2,
and samples were pooled, dialyzed against 200 volumes of 140 mM NaCl in 10 mM phosphate (pH 7.4),
and stored at -700C.
Protein measurements. To conserve toxin, protein
concentrations were monitored spectrophotometrically (15) at each stage of purification by the following
formula: 1.55(OD280 - OD315) - 0.76(OD260 -OD315)?
where OD280, OD315, and OD26o are the optical densities at 280, 315, and 260 nm, respectively. Subtraction
of OD315 readings from OD280 and OD260 values, a
modification of Layne's formula (15), was used to
negate the effects of light scattering from any particulate matter present in the samples. The protein concentrations estimated by this method were no more
than 2.5-fold different (greater or less) than values
calculated for crude samples tested by the Lowry
method (16).
Biological assays. Biological assays for toxin activity
were performed as previously described for HeLa cell
cytotoxicity (11), enterotoxicity in rabbit ileal loops
(9), and lethality for mice (21). When required, Shiga
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toxin or E. coli Shiga-like toxin activities were neutralized by rabbit anti-Shiga toxin (21).
Radioiodination. Purified and partially purified preparations of toxin from Shiga 60R and E. coli H30 were
labeled by a modification of the chloramine T method
(13). Carrier-free sodium iodide (1 mCi; Amersham
Corp., Arlington Heights, Ill.) was added to 10 to 100
,ug of toxin in 500 ,ul of 140 mM NaCl in 10 mM
phosphate (pH 7.4) buffer. The solution was then made
0.2 mM chloramine T by the addition of appropriate
quantities of concentrated reagent. After a 5-min incubation on ice, the mixture was made 0.5 mM sodium
metabisulfite and 10 mM Nal. One minute later, 100 pAl
of a 1 mg/ml solution of myoglobin was added to
prevent nonspecific absorption of the radiolabeled
toxin to the glassware. The mixture was then dialyzed
extensively against 140 mM NaCl in 10 mM phosphate
(pH 7.4).
Sucrose gradients. Radiolabeled toxin samples were
layered onto 4-ml, 10 to 40%0o sucrose gradients in 140
mM NaCI-10 mM phosphate (pH 7.4) and centrifuged
in a Beckman SW-60 rotor at 485,000 x g (60,000 rpm)
for 20 h. Fractions of 200 p.l were collected from the
tops of the tubes with a Buchler Auto Densi Flow II C
(Buchler Instruments, Fort Lee, N.J.), and the refractive index of each fraction was measured to quantitate
the percent sucrose of the sample. To locate toxin, the
radioactivity and cytotoxic activity of each fraction
was determined. The OD280 reading and the refractive
index of each fraction from a separate tube that
contained bovine serum albumin and myoglobin were
used to determine the position of the toxin relative to
these protein standards.
Immunoprecipitation. Immunoprecipitations of 125I_
labeled toxin samples were carried out as previously
described (19).
Polyacrylamide gel electrophoresis. Immunoprecipitates or samples of toxins were mixed with an
equal volume of disruption buffer (100 mM Tris [pH
7.0], 4% [wt/vol], sodium dodecyl sulfate [SDS], 10%
[wt/vol] sucrose, and 0.04% [wt/vol] bromophenol
blue). Samples were incubated in this mixture with or
without 0.7 M 2-mercaptoethanol for 20 min at 37°C
followed by 2 min at 100°C and applied to slots of a
15% acrylamide slab or cylindrical gel cross-linked
with N,N'-diallyltartardiamine. The buffer system
used was that described by Morse et al. (17). The gels
were run at 150 V constant voltage until the tracking
dye reached the bottom of the gel. The slab gels were
then fixed, dried, and exposed to Kodak XAR-5 film (5
by 7 in. [12.7 by 17.8 cm], Kodak, Rochester, N.Y.)
with an intensifier screen (Cromex Xtra Life, Du Pont
Co., Wilmington, Del.). Nondenaturing polyacrylamide gel electrophoresis was undertaken in cylindrical gels (0.5 by 10 cm) prepared as described above,
except that 10% acrylamide was used and both SDS
and 2-mercaptoethanol were omitted from the mixture. Cylindrical gels were fractionated into 2-mm
slices, and the radioactivity in each sample was quantitated. For some experiments, toxin from gel slices was
eluted into 250 pul of HeLa cell tissue culture media
(11) by overnight incubation at 40C, and the eluted
material was subsequently analyzed for cytotoxic activity. Isoelectric focusing was done in 7% bis-acrylamide gels as described by Wrigley (32).
Enzyme treatment. Purified, radiolabeled toxin from
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TABLE 1. Purification of a Shiga-like toxin from E. coli H30
Immunoprecipitability of
Recovery of
Sp act (CD5J
Total
cytotoxic
mg of
protein
Sample
125I-labeled sample with
anti-Shiga toxin (%)
activity (%)
protein)b
(mg)a
Not done
100
3 x 105
277
French press lysatec clarified
by ultracentrifugation
Affi-Gel Blue chromatography
retentate
Chromatofocus fraction at pH
7.03

24
0.15

5 x 106

160

1

3 x 108

67

18

>90
67
5 x 108
0.10
Antitoxin affinity
chromatography
a Protein concentrations were estimated spectrophotometrically by the formula given in the text.
b CD^ is the dose of toxin required to kill 509% of the approximately 16,000 cells in a microtiter well within 24
h.
c Cultures (8 liters) were grown for 48 h in iron-depleted (i.e., Chelex-treated) modified syncase broth.

Shiga 60R or E. coli H30 was added to an equal volume
of trypsin (diphenyl carbamyl treated, Sigma Chemical
Co., St. Louis, Mo.) or a-chymotrypsin (Sigma) in 10
mM phosphate with 140 mM NaCl (pH 7.4) to give a
final enzyme concentration of 10 ,ug/ml. The mixtures
were incubated for 4 h at 37rC. An excess (20 Fg/ml) of
egg white trypsin inhibitor (Sigma) was added to the
trypsin-exposed toxin. All samples were frozen at
-200C.
Cross-linking. Radiolabeled, purified toxin from
Shiga 60R or E. coli H30 was cross-linked with dimethyl suberimidate (Pierce Chemical Co., Rockford,
Ill.) in 1 M triethanolamine-100 mM sodium carbonate
(pH 8.5) as detailed by Davies and Stark (6). Dimethyl
suberimidate was added at a final concentration of 1,
6, or 12 mg/ml and allowed to react with toxin (106

cpm/ml) for 19 h at room temperature. Disruption
buffer was then added, and the samples were subjected
to SDS-polyacrylamide slab gel electrophoresis.

RESULTS
Purification of Shiga-like toxin from E. coli
H30. The method developed to obtain purified
toxin from cell extracts of E. coli H30 incorporates several techniques which have been successfully used to purify Shiga toxin, i.e., AffiGel Blue column chromatography (23) and
antitoxin affinity chromatography (19), plus a
new step, chromatofocusing, that separates proteins by their isoelectric points (28, 29). During
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FIG. 2. SDS-polyacrylamide gel electrophoresis of
unreduced E. coli H30 and Shiga 60R toxins. Purified
toxins were labeled with 125I and immunoprecipitated
with immune or preimmune sera or treated with various enzymes or cross-linking reagents; the preparations were then subjected to SDS-polyacrylamide gel
electrophoresis in 15% slab gels. The gels were dried
and evaluated by autoradiography. Lanes: A, E. coli
H30 toxin immunoprecipitated with preimmune rabbit
serum (no bands); B, E. coli H30 toxin immunoprecipitated with rabbit anti-Shiga 60R toxin; C, E. coli H30
toxin, no treatment; D, E. coli H30 toxin pretreated
with trypsin; E, E. coli H30 toxin pretreated with achymotrypsin; F, E. coli H30 toxin cross-linked with 1
mg of dimethyl suberimidate per ml; G, E. coli H30
toxin cross-linked with 6 mg of dimethyl suberimidate
per ml; H, E. coli H30 toxin cross-linked with 12 mg of
dimethyl suberimidate per ml; I, Shiga 60R toxin
immunoprecipitated with preimmune rabbit serum (no
bands); J, Shiga 60R toxin immunoprecipitated with
rabbit anti-Shiga 60R toxin; K, Shiga 60R toxin, no
treatment; L, Shiga 60R toxin, pretreated with trypsin;
M, Shiga 60R toxin, pretreated with a-chymotrypsin;
N, Shiga 60R toxin cross-linked with 1 mg of dimethyl
suberimidate per ml; 0, Shiga 60R toxin, cross-linked
with 6 mg of dimethyl suberimidate per ml; P, Shiga
60R toxin, cross-linked with 12 mg of dimethyl suberimidate per ml; Q, 14C-labeled molecular weight standards, bovine serum albumin (68,000), ovalbumin
(45,000), carbonic anhydrase (30,000), lysozyme
(14,000), aprotinin (6,000).

increase in toxin yield as determined by cytotoxic activity after Affi-Gel Blue chromatography
was a reproducible phenomenon and could indicate that an inhibitor was removed from the
crude extract by this step. Second, estimates of
the purity of toxin after the chromatofocusing
step or after the affinity chromatography step
were probably evaluated more accurately by the
percent immunoprecipitability of toxin with antitoxin than when determined by the specific
activity of toxin because toxin was diluted in 10fold increments for tests of cytotoxic activity,
whereas undiluted radiolabeled toxin was tested
for immunoprecipitability.
Evidence that E. coli H30 toxin was in fact
purified to homogeneity by the protocol delineated in Table 1 was obtained from polyacrylamide gel electrophoresis. Under nondenaturing
conditions, both cytotoxic activity of E. coli H30
toxin and its associated radioactivity comigrated
(Fig. 1). Furthermore, when radiolabeled toxin
was subjected to SDS-polyacrylamide slab gel
electrophoresis (Fig. 2), two bands of Mr approximately 31,500 (±1,000) and 4,000 to 15,000
were seen. The broad band of Mr 4,000 to 15,000
could be narrowed to a range of Mr 4,000 to
11,000 by decreasing the time of X-ray exposure, but the 31,500 Mr band was much less
distinct under those circumstances. These two
bands were also evident when gels were stained
with Coomassie blue, but the bands were too
faint to be photographed well. In the presence of
2-mercaptoethanol, three bands of Mr 31,500
(±1,000), 27,000, and 4,000 to 15,000 were observed (Fig. 3). However, the 31,500 Mr band

-

-68,000 d
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45,000 d
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the design of this protocol, the purity of toxin at
each step was assessed by radiolabeling samples
and by determining the percentage of radioactivity that was immunoprecipitable with monospecific antitoxin. As toxin is now routinely purified, only samples of the final product are
radioiodinated and checked for purity by immunoprecipitability with antitoxin and by the
mobility of radiolabeled toxin after SDS-polyacrylamide gel electrophoresis (see below). In
addition, myoglobin is added at a final concentration of 0.1% (wt/vol) to all purified toxin
samples to prevent the material from nonspecifically adhering to glassware.
The details of yield, purity, and specific activity of the E. coli H30 toxin for a typical preparation are given in Table 1. Two discrepancies in
the data warrant comment. First, the apparent
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FIG. 3. SDS-polyacrylamide gel electrophoresis of
reduced E. coli H30 and Shiga 60R toxins were labeled
and treated as in Fig. 2, except that before electrophoresis all samples were reduced with 2-mercaptoethanol. Lanes A to H and N to Q contain the reduced
samples corresponding to the unreduced samples in
lanes A to H and N to Q in Fig. 2. Lanes I to M of this
gel were not clearly resolved and are not shown.
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limitations in the amounts of purified toxins
available to perform multiple assays. The molecular basis for these biological activities is beCytotoxic Enterotoxic
lieved to be inhibition of protein synthesis in
Source of toxin for HeLa
rabbit ileal dose 50% for
eucaryotic cells (3, 4, 24, 31).
cellsa (pg) segmentsb(q±g) micec (ig
(ii) Estimates of molecular weights of native
toxins. Olsnes and Eiklid (22) observed that the
1
1
S. dysenteriae
0.10
1 60R
peaks of radioactivity and toxicity associated
E. coli H30
1
0.2
2
with Shiga toxin cosedimented on a sucrose
The dose of purified toxin required to kill 50% of gradient at a position which indicated a molecuthe approximately 16,000 HeLa cells (11) in a microti- lar weight for Shiga toxin greater than that of
bovine serum albumin (68,000) but less than that
ter well within 24 h.
b The dose of toxin required to cause .10 ml offluid of transferrin (85,000). The profile of purified
secretion in a 10-cm ligated segment of rabbit ileum in Shiga 60R toxin on a sucrose gradient prepared
50%o of the loops tested.
in this laboratory (Fig. 4A) supports the finding
cThe 50% lethal dose for a 20-g outbred CD-1 of Olsnes and Eiklid of a molecular weight
mouse given toxin intraperitoneally. All of the mice greater than 68,000. By contrast, radioactivity
which succumbed to the effects of these toxins exhibit- and cytotoxicity of E. coli H30 toxin cosedied hind-leg paralysis before death.
mented on a sucrose gradient at a location that
suggests a molecular weight of less than 68,000
(bovine serum albumin) (Fig. 4B). Molecular
was absent when toxin was both enzymatically weight estimates of Shiga 60R toxin and E. coli
nicked with trypsin and reduced with 2-mercap- H30 toxin obtained by gel filtration also suggest
toethanol (Fig. 3). The mobilities of these E. coli differences in the sizes of the two toxins, alH30 toxin bands after the various treatment though the values obtained for both toxins were
protocols and the observation that more radiola- aberrantly low for reasons that are not clear.
bel was associated with the 4,000 to 15,000 Mr Shiga 60R toxin appeared to have a molecular
band than with the 31,500 Mr component is weight of 32,000 when chromatographed on a
consistent with the appearance of similarly treat- Sephacryl S-200 (Pharmacia) column (19),
ed Shiga 60R toxin (2, 19, 22, 23; Fig. 2 and 3). whereas the molecular weight estimate obtained
Further evidence which substantiates the sup- for E. coli H30 toxin on the same column was
position that the E. coli toxin preparations were consistently lower (25,000 to 28,000; data not
pure and which also verifies the antigenic rela- shown). Shiga 60R toxin had an apparent molectionship betwen Shiga toxin and E. coli H30 ular weight of 45,000 on a Bio-Gel P-100 column
toxin was obtained from immunoprecipitation (Bio-Rad) run under the same buffer conditions
studies. The final E. coli toxin product was and calibrated with the same standards as previ>90% immunoprecipitable with antitoxin pre- ously described for Sephacryl S-200 columns
pared against purified Shiga 60R toxin but was (19), a difference which may reflect an interacnot immunoprecipitable with monospecific anti- tion of toxin with the carbohydrate-containing
toxin raised against purified cholera enterotoxin Sephacryl gel.
or purified E. coli heat-labile toxin (rabbit anti(iii) Arrangement of subunits. Cross-linking
cholera toxin and rabbit anti-heat-labile E. coli studies were performed to compare the molecutoxin were gifts of Randall Holmes, Uniformed lar organization of the subunits of purified Shiga
Services University of the Health Sciences).
60R and E. coli H30 toxins. Different concentraComparison of the characteristics of E. coli H30 tions of dimethyl suberimidate were used (1, 6,
and Shiga 60R toxins. (i) Biological activities. The and 12 mg/ml), and the cross-linked toxin prepaspecific activity of purified E. coli H30 toxin rations were then subjected to SDS-polyacrylvaried from 5 x 108 CD50 (50% HeLa cell amide gel electrophoresis in the absence or
cytotoxic dose) to 1 x 109 CD50 per mg of toxin presence of 2-mercaptoethanol (Fig. 2 and 3). A
with separate lots of toxin. Thus, like Shiga concentration of 6 mg/ml of the cross-linking
toxin (18), approximately 1 pg of toxin was a reagent was judged to give the best results, i.e.,
cytotoxic dose for HeLa cells. Moreover, puri- the most well-resolved complexes. Therefore,
fied E. coli H30 toxin also resembled Shiga toxin the molecular weights of complexes formed un(2, 19) in that it was enterotoxic for rabbit ileal der these conditions were estimated, and the
segments and was paralytic and lethal for mice. possible subunit arrangements were determined
The specific biological activities of the two tox- (Table 3). The B subunit was given an estimated
ins are compared in Table 2. The significance of Mr of 4,000 from a plot of presumed numbers of
differences between Shiga 60R and E. coli H30 B chains versus estimated molecular weight of
in the dose of toxin required for enterotoxicity the complex, a technique described by Olsnes et
and lethality cannot be evaluated because of al. (23). From these findings, it again appeared
a
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cross-links reflects their spatial arrangement in
the oligomer.
(iv) Isoelectric points. Biologically active Shiga
60R toxin had an isoelectric point of 7.03, as
averaged from four separate analyses (Fig. SA).
The average isoelectric point of the biologically
inactive B subunit was 5.67. Similarly, E. coli
H30 cytotoxin had an isoelectric point of 7.01
(Fig. SB, peak I), whereas the B subunit (peak
II, as confirmed by appearance on a gel, not
shown) had an isoelectric point of 5.66. Differences in the relative heights of peaks I and II for
Shiga 60R and E. coli H30 toxin after isoelectric
focusing (Fig. 5A and 5B, respectively) probably
reflect different ratios of intact toxin to B subunit.
(v) Relative heat stability. Both Shiga 60R and
E. coli H30 toxin retained full biological activity
after exposure to temperatures between 37 and
65°C for 30 min in 10 mM phosphate (pH 7.4).
Both toxins were completely inactivated by boiling for 2 min.
FRACTION #

40%

10%

DISCUSSION
Toxin purified from E. coli H30 is biologically
and structurally similar to Shiga 60R toxin.
Toxins from both organisms are cytotoxic for
HeLa cells at picogram doses, and both toxins
are lethal for mice and enterotoxic for rabbits in
microgram or submicrogram doses. Each toxin
consists of an A subunit (Mr = 31,500 ± 1,000)
and several copies of a B subunit (Mr about
4,000). The A subunit can be nicked by trypsin
or by endogenous proteases to form an A1
component (Mr = 27,000) and either an A2
component (Mr - 4,500), the existence of which
4-I
has not been verified by resolution of a distinct
band
on polyacrylamide gel electrophoresis (23),
5
~~~~~~~~~~~~104
or several peptide fragments. The function of
each toxin in the normal physiology of the
bacterial cell has not been investigated. Moreover, the genetic mechanisms responsible for
toxin production have not been determined for
either E. coli or shigellae.
40%
FRACTION #
10%
Although the studies reported herein showed
FIG. 4. Sucrose gradient centrifugation of 125I-labeled Shiga 60R toxin (A) and E. coli H30 toxin (B). that E. coli H30 and Shiga 60R toxins were
The 10 to 40% sucrose gradients were prepared and nearly indistinguishable, subtle differences becentrifuged as described in the text. Fractions were tween the toxins were observed. Despite the
obtained and evaluated for refractive index, radioac- limitations described above for each method
tivity, OD280, or cytotoxic activity as detailed in the used to evaluate the molecular weights of the
text.
native toxins, i.e., sucrose gradient, gel filtration, and toxin cross-linking, the results from all
three procedures indicated that E. coli H30 toxin
that the molecular weight of native Shiga toxin had a lower molecular weight (estimated as
(estimated as 58,000) was greater than that of E. 48,000 by cross-linking studies) than Shiga 60R
coli toxin (estimated as 48,000). It should be toxin (estimated as 58,000 by cross-linking studemphasized that estimations of molecular ies). The cross-linking results suggest that the
weights from cross-linking data are accurate variation in toxin size occurs because native E.
only if the capacity of the protomers to form coli H30 toxin has fewer copies of the B subunit
x

z

05

6

7

8

91011121314151617181920
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TABLE 3. Subunit complexes formed after cross-linking E. coli H30 toxin or Shiga 60R toxin
Source of
toxin

Treated with
2-mercaptoethanol

Estimated Mrb

Possible subunit arrangementc

No

48,000
43,000
40,000
31,500*
20,000
15,000-4,000*

A + 4B
A + 3B
A + 2B
A
SB
Mixture of 1B, 2B, 3B, and 4B

E. coli H30

Yes

44,000
40,000
38,000
31,500
27,000
24,000-22,000
20,000
15,000-4,000*

A + 3B
A + 2B
A1 + 3B
A
A1
SB + A2
SB
Mixture of 1B, 2B, 3B, 4B, and A2

Shiga 60R

No

58,000
53,000
49,000
43,000*
40,000*
31,500*
27,000*
20,000*
15,000-4,000

A + 6B
A + SB
A + 4B
A + 3B
A + 2B
A
A1 (partially nicked sample?)
SB
Mixture of 1B, 2B, 3B, and 4B

Shiga 60R

Yes

e. coli H30
7

r--.

TT'I^

w

58,000
A + 6B
44,000
A + 3B
40,000
A + 2B
35,000
A1 + 2B
31,500*
A
27,000
A1
24,000-22,000*
SB + A2
15,000-4,000
Mixture of 1B, 2B, 3B, 4B, and A2
a
125I-labeled toxins were cross-linked by exposure to dimethyl suberimidate at a final concentration of 6 mg/
ml as described by Davies and Stark (6). The reaction mixtures were then subjected to SDS-polyacrylamide gel
electrophoresis in a 15% slab gel with or without pre-exposure to 0.7 M 2-mercaptoethanol.
b For the purpose of comparing these findings with previously reported cross-linking results on Shiga toxin,
the arrangement of this table is patterned after the data presentation in Table 2 of reference 23. Very heavy bands
are indicated with an asterisk. Very faint bands are underlined. Diffuse bands are indicated by a range of
estimated molecular weights.
c B is given an estimated M, of 4,000; A2 is given an estimated Mr of 4,500 from the difference in M, of A and
A1.

(estimated four) than does Shiga 60R toxin (estimated six). Alternatively, E. coli H30 native
toxin may have the same Mr as Shiga 60R toxin
but may dissociate more readily during purification because of differences in the strength of the
hydrophobic interactions between the subunits.
That Shiga 60R toxin may actually have more
than six B subunits is suggested by the observation that toxin appears larger than bovine serum
albumin on repeated analyses by sucrose gradient.

Another apparent difference between the E.
coli H30 toxin and the Shiga 60R toxin is that
little of the E. coli toxin in any preparation
existed in the "nicked" (i.e., A1) form (see Fig.
2). The E. coli H30 toxin had to be treated with
trypsin and reduced with 2-mercaptoethanol to
appear in the A1 form. By contrast, most preparations of the Shiga 60R toxin were already
partially nicked (presumably by endogenous
proteases) and reduced, as could be seen on gels
even in the absence of 2-mercaptoethanol (Fig.
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and E. coli H30 toxins at the molecular level,
e.g., amino acid sequencing and mechanisms of
inhibition of protein synthesis, is required to
define more clearly the similarities and differences between the family members. Finally, the
role of Shiga toxin (if any) in the pathogenesis of
shigellosis or of the Shiga-like toxin in certain E.
coli diarrheal diseases remains to be determined.
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